Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Benjamin Szilagyi"'
Publikováno v:
Citováno v: SDK, 345
Citováno v: Dokoupil: Soupis komenian, s. 26, č. 46
Citováno v: Vobr: Dílo J. A. Komenského, 140
Citováno v: Dokoupil: Soupis komenian, s. 26, č. 46
Citováno v: Vobr: Dílo J. A. Komenského, 140
Autor:
Dante diTommaso, Benjamin Szilagyi
Publikováno v:
Pharmaceutical Programming. 1:42-50
Sometimes the simplest SAS® task can become unnecessarily complex. Often the complexity of SAS®, itself, is the cause. Crucial details are easily hidden among the thousands of pages of SAS® documentation, technical notes, release updates, etc. The
Autor:
Stephen Bamford, Benjamin Szilagyi
Publikováno v:
Pharmaceutical Programming. 3:37-38
At this year’s FDA-DIA Conference for Computational Science, PhUSE had the opportunity to meet with representatives from the FDA and CDISC to discuss the status quo of industry standards and what opportunities lay ahead for further alignment and si
Autor:
Mat Soukup, Benjamin Szilagyi
Publikováno v:
Pharmaceutical Programming. 3:43-43
Autor:
Kokje, Milind milind.kokje@mmactiv.com
Publikováno v:
BioSpectrum. Jan2020, Vol. 18 Issue 1, p39-40. 2p.
Autor:
Bamford, Stephen, Szilagyi, Benjamin
Publikováno v:
Pharmaceutical Programming. Jun2010, Vol. 3 Issue 1, p37-38. 2p. 2 Diagrams.
Autor:
Brown Weiss, Edith
Publikováno v:
Collected Courses of the Hague Academy of International Law
Externí odkaz:
http://dx.doi.org/10.1163/1875-8096_pplrdc_A9789004172883_02
Autor:
Soukup, Mat, Szilagyi, Benjamin
Publikováno v:
Pharmaceutical Programming. Dec2010, Vol. 3 Issue 2, p43-43. 1p.
Autor:
Spruck, Dirk
Publikováno v:
Pharmaceutical Programming. Jun2010, Vol. 3 Issue 1, p3-3. 1p.
Autor:
Spruck, Dirk
Publikováno v:
Pharmaceutical Programming. Aug2009, Vol. 2 Issue 1, p3-3. 1p.